Lacosamide: a study of exposures reported to US poison centers over a 9-year period - Teijido J, Kempf D, Laubach E, Zosel A, Borys D.

BACKGROUND: Lacosamide (Vimpat ®) is an anticonvulsant used to treat partial-onset seizures. Little is known about the characteristics and outcomes of patients exposed to lacosamide. OBJECTIVE: To characterize lacosamide exposures reported to US po...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news